nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—TYK2—type 1 diabetes mellitus	0.652	1	CbGaD
Ruxolitinib—RET—autonomic nervous system—type 1 diabetes mellitus	0.0044	0.0402	CbGeAlD
Ruxolitinib—GRK7—retina—type 1 diabetes mellitus	0.0037	0.0338	CbGeAlD
Ruxolitinib—CAMK2G—nerve—type 1 diabetes mellitus	0.00291	0.0266	CbGeAlD
Ruxolitinib—MAP3K3—peripheral nervous system—type 1 diabetes mellitus	0.00289	0.0264	CbGeAlD
Ruxolitinib—LRRK2—nerve—type 1 diabetes mellitus	0.00288	0.0264	CbGeAlD
Ruxolitinib—GRK1—retina—type 1 diabetes mellitus	0.00267	0.0244	CbGeAlD
Ruxolitinib—PLK3—islet of Langerhans—type 1 diabetes mellitus	0.00245	0.0224	CbGeAlD
Ruxolitinib—PRKG2—cardiovascular system—type 1 diabetes mellitus	0.00237	0.0217	CbGeAlD
Ruxolitinib—PRKG2—kidney—type 1 diabetes mellitus	0.00232	0.0212	CbGeAlD
Ruxolitinib—RPS6KA6—cardiovascular system—type 1 diabetes mellitus	0.00213	0.0194	CbGeAlD
Ruxolitinib—JAK1—islet of Langerhans—type 1 diabetes mellitus	0.00188	0.0172	CbGeAlD
Ruxolitinib—PLK1—lymphoid tissue—type 1 diabetes mellitus	0.00179	0.0163	CbGeAlD
Ruxolitinib—PLK3—cardiovascular system—type 1 diabetes mellitus	0.00177	0.0162	CbGeAlD
Ruxolitinib—STK16—islet of Langerhans—type 1 diabetes mellitus	0.00177	0.0161	CbGeAlD
Ruxolitinib—PLK3—pancreas—type 1 diabetes mellitus	0.00172	0.0158	CbGeAlD
Ruxolitinib—DAPK3—islet of Langerhans—type 1 diabetes mellitus	0.00169	0.0154	CbGeAlD
Ruxolitinib—CAMK1D—retina—type 1 diabetes mellitus	0.00157	0.0144	CbGeAlD
Ruxolitinib—JAK1—nephron tubule—type 1 diabetes mellitus	0.00152	0.0139	CbGeAlD
Ruxolitinib—NUAK2—islet of Langerhans—type 1 diabetes mellitus	0.0015	0.0138	CbGeAlD
Ruxolitinib—HIPK2—nephron tubule—type 1 diabetes mellitus	0.00141	0.0129	CbGeAlD
Ruxolitinib—ROCK1—retina—type 1 diabetes mellitus	0.00139	0.0127	CbGeAlD
Ruxolitinib—JAK1—cardiovascular system—type 1 diabetes mellitus	0.00136	0.0124	CbGeAlD
Ruxolitinib—JAK1—kidney—type 1 diabetes mellitus	0.00133	0.0122	CbGeAlD
Ruxolitinib—JAK1—pancreas—type 1 diabetes mellitus	0.00132	0.0121	CbGeAlD
Ruxolitinib—CAMK1D—pancreas—type 1 diabetes mellitus	0.00129	0.0118	CbGeAlD
Ruxolitinib—HIPK2—cardiovascular system—type 1 diabetes mellitus	0.00127	0.0116	CbGeAlD
Ruxolitinib—TYK2—islet of Langerhans—type 1 diabetes mellitus	0.00124	0.0114	CbGeAlD
Ruxolitinib—HIPK2—kidney—type 1 diabetes mellitus	0.00124	0.0114	CbGeAlD
Ruxolitinib—HIPK2—pancreas—type 1 diabetes mellitus	0.00124	0.0113	CbGeAlD
Ruxolitinib—IRAK1—islet of Langerhans—type 1 diabetes mellitus	0.00123	0.0112	CbGeAlD
Ruxolitinib—MKNK2—islet of Langerhans—type 1 diabetes mellitus	0.00123	0.0112	CbGeAlD
Ruxolitinib—DAPK3—cardiovascular system—type 1 diabetes mellitus	0.00122	0.0112	CbGeAlD
Ruxolitinib—NUAK2—nephron tubule—type 1 diabetes mellitus	0.00121	0.0111	CbGeAlD
Ruxolitinib—DAPK3—pancreas—type 1 diabetes mellitus	0.00119	0.0108	CbGeAlD
Ruxolitinib—ROCK1—cardiovascular system—type 1 diabetes mellitus	0.00117	0.0107	CbGeAlD
Ruxolitinib—JAK3—lymphoid tissue—type 1 diabetes mellitus	0.00115	0.0105	CbGeAlD
Ruxolitinib—ROCK1—kidney—type 1 diabetes mellitus	0.00115	0.0105	CbGeAlD
Ruxolitinib—JAK1—lymphoid tissue—type 1 diabetes mellitus	0.00114	0.0105	CbGeAlD
Ruxolitinib—DYRK1A—cardiovascular system—type 1 diabetes mellitus	0.00114	0.0105	CbGeAlD
Ruxolitinib—BMPR2—cardiovascular system—type 1 diabetes mellitus	0.00114	0.0104	CbGeAlD
Ruxolitinib—PLK4—lymphoid tissue—type 1 diabetes mellitus	0.00114	0.0104	CbGeAlD
Ruxolitinib—DYRK1A—kidney—type 1 diabetes mellitus	0.00112	0.0102	CbGeAlD
Ruxolitinib—BMPR2—kidney—type 1 diabetes mellitus	0.00111	0.0102	CbGeAlD
Ruxolitinib—MAP3K7—retina—type 1 diabetes mellitus	0.00108	0.00991	CbGeAlD
Ruxolitinib—STK16—lymphoid tissue—type 1 diabetes mellitus	0.00107	0.00981	CbGeAlD
Ruxolitinib—HIPK2—lymphoid tissue—type 1 diabetes mellitus	0.00107	0.00976	CbGeAlD
Ruxolitinib—TYK2—retina—type 1 diabetes mellitus	0.00106	0.00973	CbGeAlD
Ruxolitinib—NUAK2—pancreas—type 1 diabetes mellitus	0.00106	0.00967	CbGeAlD
Ruxolitinib—MKNK2—retina—type 1 diabetes mellitus	0.00105	0.0096	CbGeAlD
Ruxolitinib—MAP3K2—nephron tubule—type 1 diabetes mellitus	0.00103	0.00942	CbGeAlD
Ruxolitinib—CAMK2G—cardiovascular system—type 1 diabetes mellitus	0.00102	0.00932	CbGeAlD
Ruxolitinib—CLK2—lymphoid tissue—type 1 diabetes mellitus	0.00102	0.00929	CbGeAlD
Ruxolitinib—TYK2—nephron tubule—type 1 diabetes mellitus	0.001	0.00916	CbGeAlD
Ruxolitinib—TAOK3—islet of Langerhans—type 1 diabetes mellitus	0.000995	0.0091	CbGeAlD
Ruxolitinib—CAMK2G—pancreas—type 1 diabetes mellitus	0.00099	0.00905	CbGeAlD
Ruxolitinib—IRAK1—nephron tubule—type 1 diabetes mellitus	0.000989	0.00904	CbGeAlD
Ruxolitinib—MKNK2—nephron tubule—type 1 diabetes mellitus	0.000989	0.00904	CbGeAlD
Ruxolitinib—LRRK2—kidney—type 1 diabetes mellitus	0.000988	0.00903	CbGeAlD
Ruxolitinib—ROCK1—lymphoid tissue—type 1 diabetes mellitus	0.000985	0.00901	CbGeAlD
Ruxolitinib—DYRK1A—lymphoid tissue—type 1 diabetes mellitus	0.000961	0.00878	CbGeAlD
Ruxolitinib—BMPR2—lymphoid tissue—type 1 diabetes mellitus	0.000957	0.00875	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—type 1 diabetes mellitus	0.0009	0.00823	CbGeAlD
Ruxolitinib—MKNK2—cardiovascular system—type 1 diabetes mellitus	0.000888	0.00812	CbGeAlD
Ruxolitinib—TYK2—kidney—type 1 diabetes mellitus	0.000881	0.00805	CbGeAlD
Ruxolitinib—MAP3K3—nephron tubule—type 1 diabetes mellitus	0.000879	0.00803	CbGeAlD
Ruxolitinib—TYK2—pancreas—type 1 diabetes mellitus	0.000875	0.008	CbGeAlD
Ruxolitinib—MKNK2—pancreas—type 1 diabetes mellitus	0.000863	0.00789	CbGeAlD
Ruxolitinib—IRAK1—pancreas—type 1 diabetes mellitus	0.000863	0.00789	CbGeAlD
Ruxolitinib—TAOK3—retina—type 1 diabetes mellitus	0.000851	0.00778	CbGeAlD
Ruxolitinib—RET—kidney—type 1 diabetes mellitus	0.000848	0.00775	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—type 1 diabetes mellitus	0.000819	0.00749	CbGeAlD
Ruxolitinib—JAK2—kidney—type 1 diabetes mellitus	0.000801	0.00732	CbGeAlD
Ruxolitinib—TAOK3—nephron tubule—type 1 diabetes mellitus	0.000801	0.00732	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—type 1 diabetes mellitus	0.000789	0.00722	CbGeAlD
Ruxolitinib—MAP3K2—lymphoid tissue—type 1 diabetes mellitus	0.000778	0.00711	CbGeAlD
Ruxolitinib—TYK2—lymphoid tissue—type 1 diabetes mellitus	0.000756	0.00692	CbGeAlD
Ruxolitinib—MKNK2—lymphoid tissue—type 1 diabetes mellitus	0.000747	0.00683	CbGeAlD
Ruxolitinib—RET—lymphoid tissue—type 1 diabetes mellitus	0.000728	0.00666	CbGeAlD
Ruxolitinib—TAOK3—cardiovascular system—type 1 diabetes mellitus	0.00072	0.00658	CbGeAlD
Ruxolitinib—TAOK3—kidney—type 1 diabetes mellitus	0.000704	0.00644	CbGeAlD
Ruxolitinib—TAOK3—pancreas—type 1 diabetes mellitus	0.000699	0.00639	CbGeAlD
Ruxolitinib—JAK2—lymphoid tissue—type 1 diabetes mellitus	0.000688	0.00629	CbGeAlD
Ruxolitinib—TAOK3—lymphoid tissue—type 1 diabetes mellitus	0.000605	0.00553	CbGeAlD
Ruxolitinib—CYP3A4—kidney—type 1 diabetes mellitus	0.000214	0.00196	CbGeAlD
Ruxolitinib—PRKCE—Disease—STAT3—type 1 diabetes mellitus	6.92e-06	2.91e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CD80—type 1 diabetes mellitus	6.92e-06	2.91e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.91e-06	2.9e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL2—type 1 diabetes mellitus	6.9e-06	2.9e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.9e-06	2.9e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.89e-06	2.89e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—STAT3—type 1 diabetes mellitus	6.87e-06	2.88e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	6.86e-06	2.88e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD8A—type 1 diabetes mellitus	6.85e-06	2.88e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—EGFR—type 1 diabetes mellitus	6.82e-06	2.86e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD80—type 1 diabetes mellitus	6.8e-06	2.86e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.8e-06	2.85e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.79e-06	2.85e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—type 1 diabetes mellitus	6.76e-06	2.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	6.76e-06	2.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—type 1 diabetes mellitus	6.75e-06	2.84e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—STAT3—type 1 diabetes mellitus	6.71e-06	2.82e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.7e-06	2.81e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.68e-06	2.81e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD80—type 1 diabetes mellitus	6.6e-06	2.77e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-B—type 1 diabetes mellitus	6.59e-06	2.77e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—INS—type 1 diabetes mellitus	6.54e-06	2.75e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—IL6—type 1 diabetes mellitus	6.53e-06	2.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD86—type 1 diabetes mellitus	6.52e-06	2.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	6.51e-06	2.74e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1B—type 1 diabetes mellitus	6.49e-06	2.73e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—type 1 diabetes mellitus	6.49e-06	2.73e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS2—type 1 diabetes mellitus	6.47e-06	2.72e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL2—type 1 diabetes mellitus	6.47e-06	2.72e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—EGFR—type 1 diabetes mellitus	6.46e-06	2.71e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.45e-06	2.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—IL6—type 1 diabetes mellitus	6.4e-06	2.69e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ERBB3—type 1 diabetes mellitus	6.37e-06	2.67e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—STAT3—type 1 diabetes mellitus	6.33e-06	2.66e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.33e-06	2.66e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.3e-06	2.64e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—EGFR—type 1 diabetes mellitus	6.29e-06	2.64e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SST—type 1 diabetes mellitus	6.29e-06	2.64e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD80—type 1 diabetes mellitus	6.28e-06	2.64e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—EGFR—type 1 diabetes mellitus	6.27e-06	2.63e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	6.26e-06	2.63e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.26e-06	2.63e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—EGFR—type 1 diabetes mellitus	6.24e-06	2.62e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CD86—type 1 diabetes mellitus	6.21e-06	2.61e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2RA—type 1 diabetes mellitus	6.17e-06	2.59e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL6—type 1 diabetes mellitus	6.13e-06	2.58e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-A—type 1 diabetes mellitus	6.11e-06	2.56e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—EGFR—type 1 diabetes mellitus	6.1e-06	2.56e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—EGFR—type 1 diabetes mellitus	6.08e-06	2.55e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.07e-06	2.55e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CD86—type 1 diabetes mellitus	6.03e-06	2.53e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.96e-06	2.5e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—INS—type 1 diabetes mellitus	5.93e-06	2.49e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—STAT3—type 1 diabetes mellitus	5.92e-06	2.49e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—TYK2—type 1 diabetes mellitus	5.91e-06	2.48e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.89e-06	2.47e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—ERBB3—type 1 diabetes mellitus	5.88e-06	2.47e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.86e-06	2.46e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CD86—type 1 diabetes mellitus	5.85e-06	2.45e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.84e-06	2.45e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—EGFR—type 1 diabetes mellitus	5.84e-06	2.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—type 1 diabetes mellitus	5.82e-06	2.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—IL6—type 1 diabetes mellitus	5.8e-06	2.43e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CCR5—type 1 diabetes mellitus	5.78e-06	2.43e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.77e-06	2.42e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.77e-06	2.42e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—type 1 diabetes mellitus	5.76e-06	2.42e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—EGFR—type 1 diabetes mellitus	5.75e-06	2.42e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.74e-06	2.41e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.73e-06	2.41e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.72e-06	2.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—HLA-A—type 1 diabetes mellitus	5.64e-06	2.37e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—INS—type 1 diabetes mellitus	5.63e-06	2.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GCG—type 1 diabetes mellitus	5.6e-06	2.35e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.6e-06	2.35e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DRB1—type 1 diabetes mellitus	5.58e-06	2.34e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TYK2—type 1 diabetes mellitus	5.57e-06	2.34e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.55e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—type 1 diabetes mellitus	5.54e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—INS—type 1 diabetes mellitus	5.53e-06	2.32e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.51e-06	2.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—type 1 diabetes mellitus	5.46e-06	2.29e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—STAT3—type 1 diabetes mellitus	5.44e-06	2.29e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.44e-06	2.29e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.43e-06	2.28e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.43e-06	2.28e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.42e-06	2.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	5.39e-06	2.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—EGFR—type 1 diabetes mellitus	5.38e-06	2.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—type 1 diabetes mellitus	5.38e-06	2.26e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.35e-06	2.25e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—type 1 diabetes mellitus	5.35e-06	2.25e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.34e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.33e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.27e-06	2.21e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.27e-06	2.21e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—type 1 diabetes mellitus	5.24e-06	2.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.24e-06	2.2e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.23e-06	2.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5.22e-06	2.19e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.22e-06	2.19e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—type 1 diabetes mellitus	5.21e-06	2.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—type 1 diabetes mellitus	5.2e-06	2.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—type 1 diabetes mellitus	5.19e-06	2.18e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.18e-06	2.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD80—type 1 diabetes mellitus	5.15e-06	2.16e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—type 1 diabetes mellitus	5.13e-06	2.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.11e-06	2.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—type 1 diabetes mellitus	5.04e-06	2.11e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.03e-06	2.11e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—STAT3—type 1 diabetes mellitus	5.03e-06	2.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—type 1 diabetes mellitus	4.97e-06	2.09e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—EGFR—type 1 diabetes mellitus	4.95e-06	2.08e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.94e-06	2.08e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—type 1 diabetes mellitus	4.94e-06	2.07e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.93e-06	2.07e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—type 1 diabetes mellitus	4.92e-06	2.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—type 1 diabetes mellitus	4.9e-06	2.06e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.87e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.86e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.85e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.85e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.84e-06	2.03e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—type 1 diabetes mellitus	4.84e-06	2.03e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—type 1 diabetes mellitus	4.82e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—type 1 diabetes mellitus	4.8e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—type 1 diabetes mellitus	4.79e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—type 1 diabetes mellitus	4.79e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—type 1 diabetes mellitus	4.78e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.76e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD80—type 1 diabetes mellitus	4.76e-06	2e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	4.76e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—EGFR—type 1 diabetes mellitus	4.75e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.74e-06	1.99e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—type 1 diabetes mellitus	4.69e-06	1.97e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—type 1 diabetes mellitus	4.68e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—type 1 diabetes mellitus	4.65e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—type 1 diabetes mellitus	4.63e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—EGFR—type 1 diabetes mellitus	4.57e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CD86—type 1 diabetes mellitus	4.57e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.53e-06	1.9e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—INS—type 1 diabetes mellitus	4.5e-06	1.89e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	4.47e-06	1.88e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—type 1 diabetes mellitus	4.42e-06	1.86e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.41e-06	1.85e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CD80—type 1 diabetes mellitus	4.4e-06	1.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.36e-06	1.83e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TYK2—type 1 diabetes mellitus	4.35e-06	1.83e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.33e-06	1.82e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—INS—type 1 diabetes mellitus	4.28e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CD80—type 1 diabetes mellitus	4.26e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.19e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.18e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.16e-06	1.75e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—INS—type 1 diabetes mellitus	4.15e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—STAT3—type 1 diabetes mellitus	4.14e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.14e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—type 1 diabetes mellitus	4.14e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.12e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.12e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.11e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.09e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.09e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—type 1 diabetes mellitus	4.07e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.05e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—INS—type 1 diabetes mellitus	4.03e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—STAT3—type 1 diabetes mellitus	4.02e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.02e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TYK2—type 1 diabetes mellitus	4.02e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4e-06	1.68e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.99e-06	1.68e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.96e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—type 1 diabetes mellitus	3.94e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—type 1 diabetes mellitus	3.93e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—STAT3—type 1 diabetes mellitus	3.9e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.9e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	3.88e-06	1.63e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.82e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—type 1 diabetes mellitus	3.8e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—EGFR—type 1 diabetes mellitus	3.76e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.75e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.72e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—STAT3—type 1 diabetes mellitus	3.71e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—type 1 diabetes mellitus	3.65e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—EGFR—type 1 diabetes mellitus	3.65e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.64e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—type 1 diabetes mellitus	3.63e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—type 1 diabetes mellitus	3.63e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—type 1 diabetes mellitus	3.62e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.6e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—EGFR—type 1 diabetes mellitus	3.54e-06	1.49e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.53e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.52e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—type 1 diabetes mellitus	3.51e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.46e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—type 1 diabetes mellitus	3.39e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—EGFR—type 1 diabetes mellitus	3.37e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CD80—type 1 diabetes mellitus	3.33e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.2e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.19e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.18e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—INS—type 1 diabetes mellitus	3.15e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.15e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.09e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.09e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.07e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	3.07e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—STAT3—type 1 diabetes mellitus	3.05e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.05e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.03e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CASP3—type 1 diabetes mellitus	3e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—type 1 diabetes mellitus	3e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—type 1 diabetes mellitus	2.89e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.86e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.81e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—STAT3—type 1 diabetes mellitus	2.81e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—type 1 diabetes mellitus	2.81e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EGFR—type 1 diabetes mellitus	2.77e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.76e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—type 1 diabetes mellitus	2.72e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.68e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.6e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—type 1 diabetes mellitus	2.59e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	2.59e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EGFR—type 1 diabetes mellitus	2.56e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.52e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.46e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	2.44e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.43e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	2.42e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.42e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	2.38e-06	9.98e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.36e-06	9.92e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.34e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—type 1 diabetes mellitus	2.34e-06	9.83e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.33e-06	9.78e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.29e-06	9.62e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—type 1 diabetes mellitus	2.13e-06	8.93e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.97e-06	8.27e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—type 1 diabetes mellitus	1.96e-06	8.25e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	1.89e-06	7.95e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.87e-06	7.85e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.82e-06	7.62e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.79e-06	7.52e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—type 1 diabetes mellitus	1.76e-06	7.39e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	1.6e-06	6.73e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.38e-06	5.78e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.06e-06	4.47e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	9.76e-07	4.1e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	9.33e-07	3.92e-06	CbGpPWpGaD
